Raimon Puig De La Bellacasa

Dr. Raimon Puig De La Bellacasa

Institut Químic de Sarrià, Barcelona, Catalonia, Spain
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
ADAna Donaire-Arias
Ana Donaire-Arias
AMAna Maria Montagut
Ana Maria Montagut
RBRaimon Puig De La Bellacasa
Raimon Puig De La Bellacasa
RERoger Estrada-Tejedor
Roger Estrada-Tejedor
Jordi TeixidoJordi Teixido
Jordi Teixido
JBJose I. Borrell
Jose I. Borrell
Pyrazolo[3,4-b]pyridines are a group of heterocyclic compounds presenting two possible tautomeric forms: the 1H- and 2H-isomers. More than 300,000 1H-pyrazolo[3,4-b]pyridines have been described which are included in more than 5500 references (2400 patents) up to date. This review will cover the analysis of the diversity of the substituents present at positions N1, C3, C4, C5, and C6, the synthetic methods used for their synthesis, starting from both a preformed pyrazole or pyridine, and the biomedical applications of such compounds.

16 November 2019 in Molecules
Verified
Journal Article
Open access
PDF file
GJGuillem Jubete
Guillem Jubete
RBRaimon Puig De La Bellacasa
Raimon Puig De La Bellacasa
RERoger Estrada-Tejedor
Roger Estrada-Tejedor
Jordi TeixidoJordi Teixido
Jordi Teixido
JBJose I. Borrell
Jose I. Borrell
Pyrido[2,3-d]pyrimidines (1) are a type of privileged heterocyclic scaffolds capable of providing ligands for several receptors in the body. Among such structures, our group and others have been particularly interested in pyrido[2,3-d]pyrimidine-7(8H)-ones (2) due to the similitude with nitrogen bases present in DNA and RNA. Currently there are more than 20,000 structures 2 described which correspond to around 2900 references (half of them being patents). Furthermore, the number of references containing compounds of general structure 2 have increased almost exponentially in the last 10 years. The present review covers the synthetic methods used for the synthesis of pyrido[2,3-d]pyrimidine-7(8H)-ones (2), both starting from a preformed pyrimidine ring or a pyridine ring, and the biomedical applications of such compounds.

1 October 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RBRaimon Puig De La Bellacasa
Raimon Puig De La Bellacasa
Gael RoueGael Roue
Gael Roue
PBPatricia Balsas
Patricia Balsas
PPPatricia Pérez-Galán
Patricia Pérez-Galán
Jordi TeixidoJordi Teixido
Jordi Teixido
JBJose I. Borrell
Jose I. Borrell

1 April 2013
Verified
Journal Article
Closed access
RBRaimon Puig De La Bellacasa
Raimon Puig De La Bellacasa
NKNiki Karachaliou
Niki Karachaliou
RERoger Estrada-Tejedor
Roger Estrada-Tejedor
Jordi TeixidoJordi Teixido
Jordi Teixido
CCCarlota Costa
Carlota Costa
JBJose I. Borrell
Jose I. Borrell

10 October 2008 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
SPSofia Pettersson
Sofia Pettersson
VPVioleta I. Pérez‐Nueno
Violeta I. Pérez‐Nueno
LRLaia Ros‐Blanco
Laia Ros‐Blanco
RBRaimon Puig De La Bellacasa
Raimon Puig De La Bellacasa
MRMaría Obdulia Rabal
María Obdulia Rabal
Jordi TeixidoJordi Teixido
Jordi Teixido

1 June 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MCMarta Camarasa
Marta Camarasa
RBRaimon Puig De La Bellacasa
Raimon Puig De La Bellacasa
ÀGÀlex L. González
Àlex L. González
RORaül Ondoño
Raül Ondoño
RERoger Estrada-Tejedor
Roger Estrada-Tejedor
JBJose I. Borrell
Jose I. Borrell